Lawrence Deyton
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 10
- HIV/AIDS Research and Interventions 8
- Virology 8
- HIV Research and Treatment 8
- Co-authors
- Judith Feinberg (3 shared papers)Joseph J. Eron (2 shared papers)John Phair (1 shared paper)Lisa M. Demeter (2 shared papers)Scott M. Hammer (2 shared papers)Louise Pedneault (1 shared paper)Jon C. Cook (1 shared paper)Jeffrey Chodakewitz (2 shared papers)
- Journals
- New England Journal of Medicine (4 papers)The Lancet (3 papers)Academic Medicine (2 papers)AIDS (2 papers)PLoS ONE (1 paper)
- Partner nations
- United StatesUnited KingdomBrazil
In The Last Decade
Lawrence Deyton
32 papers receiving 3.3k citations
Lawrence Deyton's Hit Papers
Peers
Comparison fields: 5 of 125
- Virology 1.3k
- Infectious Diseases 1.7k
- Emergency Medicine 330
- Hepatology 196
- Statistics and Probability 200
Countries citing papers authored by Lawrence Deyton
This map shows the geographic impact of Lawrence Deyton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Deyton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Deyton more than expected).
Fields of papers citing papers by Lawrence Deyton
This network shows the impact of papers produced by Lawrence Deyton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Deyton. The network helps show where Lawrence Deyton may publish in the future.
Co-authors
The 25 scholars most cited alongside Lawrence Deyton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less Hit paper breakdown → | 1997 | 2128 |
| 2 | 1988 | 220 | |
| 3 | 1994 | 151 | |
| 4 | 1987 | 148 | |
| 5 | 1989 | 96 | |
| 6 | 2020 | 78 | |
| 7 | 2013 | 67 | |
| 8 | 2005 | 63 | |
| 9 | 2010 | 58 | |
| 10 | 1994 | 55 | |
| 11 | 2001 | 47 | |
| 12 | 2008 | 44 | |
| 13 | 1996 | 44 | |
| 14 | 1994 | 39 | |
| 15 | 1992 | 30 | |
| 16 | 2020 | 24 | |
| 17 | 2006 | 23 | |
| 18 | 2008 | 19 | |
| 19 | 1998 | 16 | |
| 20 | 2020 | 15 |
About Lawrence Deyton
Lawrence Deyton is a scholar working on Infectious Diseases, Virology, Epidemiology, General Health Professions and Public Health, Environmental and Occupational Health, having authored 36 papers that have together received 3.5k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (10 papers), HIV/AIDS Research and Interventions (8 papers), HIV Research and Treatment (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Primary Care and Health Outcomes (3 papers), Smoking Behavior and Cessation (3 papers), Toxoplasma gondii Research Studies (3 papers) and Global Public Health Policies and Epidemiology (3 papers). The work is most often cited by research in Virology (1.3k citations), Infectious Diseases (1.7k citations), Emergency Medicine (330 citations), Hepatology (196 citations) and Statistics and Probability (200 citations). Lawrence Deyton has collaborated with scholars based in United States, United Kingdom and Brazil. Frequent co-authors include Judith Feinberg, Joseph J. Eron, John Phair, Lisa M. Demeter, Scott M. Hammer, Louise Pedneault, Jon C. Cook, Jeffrey Chodakewitz, Kathleen Squires and Judith S. Currier. Their work appears in journals such as New England Journal of Medicine, The Lancet, Academic Medicine, AIDS and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.